Early diagnosis of pancreatic cancer with a drop of blood

On February 6, a group of US and Chinese scientists published a rapid diagnosis of pancreatic cancer cases through blood tests with less than a drop of blood. Currently this method is still in the testing process, but with the positive results achieved today, scientists believe that this method will be popular in the next 2 or 3 years, helping many people to play. early cancer, from which there is appropriate treatment.

Pancreatic cancer is a very difficult disease to detect and treat early.

During the study, the team found an EphA2 protein in pancreatic cancer cells. Later, the team studied a test method to detect the presence of this protein in 0.001 ml of serum, a liquid solution of blood that had anticoagulant and in that environment cancer cells. mail cannot grow.

The testing process shows that this new test method results in up to 85% of diagnosis of patients' incubation periods. The team confirmed that this test method should be tested at a larger research scale before being widely applied.

Pancreatic cancer is a very difficult disease to detect and treat early. The disease is only detected when cancer cells spread to the internal organs of the human body. Because there is no appropriate treatment, 80% of all deaths are reported worldwide each year.

The results of the study were published in the journal Nature Biomedical Engineering on February 6.